Private Equity

We partner with many leading conglomerates and innovative companies in Korea to address their business needs in future growth and in capital resources. Our strategy is to seek untapped opportunities where we can add value while others overlook.

photo-1486406146926-c627a92ad1ab.jfif

Venture Capital

We make investments in early-stage companies, seeking to unlock values from core-technology and management philosophy, and help the companies grow by supporting in revenue generating activities.

실험실

Our Portfolio

TBT.png

TBT

2022 Korea

Defense-specialized thermal imaging camera manufacturer buy-out deal

Future Medicine.png

Future Medicine

2020 Korea

NASH treatment biotech series investment

EnsolBio sciences.png

EnsolBio Sciences

2021 Korea

Innovative new drugs to cure the incurables investment of bio blind fund

Airovation.png

Airovation Technologies

2021 Korea

Innovative Air-Tech company that provides original, patented air purification and carbon capture solutions investment

Bertis.png

Bertis

2022 Korea

Breast cancer early diagnosis biotech(series investment) NASDAQ and KOSDAQ listing candidate

Kainos Medicine.png

Kinosmedicine

2021 Korea

 

Innovative medicines for brain diseases, cancers, and infectious disease investment of bio blind fund

onecure gen.png

Onecure gen

2021 Korea

Innovative anticancer drugs investment of bio blind fund

Autotelic Bio.png

Autotelic Bio

2021 Korea

Innovative anticancer drugs investment of bio blind fund

Pinotbio.png

Pino Bio

2021 Korea

Innovative anticancer drugs investment of bio blind fund